Features of the incidence of breast cancer in the Republic of Kazakhstan

Author:

Isputinova N. R.1,Galaeva A. I.1,Rogova S. I.1,Kalishev M. G.1,Protasova M. S.1,Nukeshtayeva K. E.1

Affiliation:

1. School of Public Health, Non-commercial joint-stock company «Karaganda Medical University»

Abstract

Aim of the study. Analysis of breast cancer incidence in Kazakhstan for the period 2020 – 2022.Materials and methods. The study included all registered cases of breast cancer morbidity and mortality in the Republic of Kazakhstan for the period 2020-2022. Data for analysis were taken from the official statistical source: Statistical collection «Health of the population of the Republic of Kazakhstan and the activities of healthcare organizations in 2020»; Statistical collection “Health of the population of the Republic of Kazakhstan and the activities of healthcare organizations in 2021-2022.” The search depth was 3 years, from 2020 to 2022. A direct standardization method using a global population standard was used to calculate standardized morbidity and mortality rates.Results and discussion. As a result of studying statistical data for 2020-2022, it was found that cancer incidence rates per 100 thousand population in 2022, compared with 2021, increased by 5.2%, and compared to 2020 increased by 13.5%. In the structure of incidence, both in 2020 and 2021, and in 2022, breast cancer occupied 1st place, with an increase in dynamics from 2020 to 2022 from 8.76 to 9.73 per 100 thousand population.An analysis of the incidence of breast cancer by stages of the disease in the context of regions of Kazakhstan showed that high rates of stages I and II of breast cancer were established in the Kyzylorda, Pavlodar, and Atyrau regions. The lowest incidence rates of stage I and II breast cancer were observed in Akmola, Mangistau and Turkestan regions.Conclusions. According to the results of our review, many studies indicate that this disease continues to be the most frequently diagnosed malignant neoplasm and the leading cause of death among women in various countries of the world, including Kazakhstan. The conclusion of this article is that the incidence and mortality from breast cancer continues to be an urgent epidemiological problem in Kazakhstan, requiring further scientific research to identify risk factors.

Publisher

Karaganda Medical University

Reference21 articles.

1. Ajmuhambetov E. N. Jepidemiologicheskie aspekty raka molochnoj zhelezy /E. N. Ajmuhambetov, Z. A. Hismetova, U. S. Samarova //Nauka i Zdravoohranenie. – 2021. – №6, T. 23. – S. 198-204.

2. Gavrilenko S. P. Rak molochnoj zhelezy ili samaja rasprostranennaja opuhol'. Diagnostika. Sovremennyj podhod k lecheniju /S. P. Gavrilenko, D. D. Obuhova, S. R. Dzhepparova //Colloquium journal. – 2021. – №15 (102). – S. 35-39.

3. Informacionno-pravovaja sistema normativnyh pravovyh aktov Respubliki Kazahstan //https://adilet.zan.kz/rus (data obrashhenija: 28.03.2024 g.)

4. Kalieva G. Rak molochnoj zhelezy: tochechno, bezopasno, jeffektivno //Kazahstanskij medicinskij zhurnal. – 2014. – №5 (41). – S. 27-29.

5. Kozhamberdina M. K. Ocenka jeffektivnosti skrininga molochnoj zhelezy /M. K. Kozhamberdina, B. N. Ryskulov, A. Zhumabekkyzy //Mater. mezhdunar. stud. nauch. konf. «Studencheskij nauchnyj forum – 2020». – M., 2020. – №1. – S. 13-17.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3